Related Experiment Video
Updated: Jul 12, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
Heart failure and cardiac hypertrophy
J Eduardo Rame1, Daniel L Dries
1Division of Cardiology, University of California San Francisco, 505 Parnassus Avenue, Box 0124 M1177C, San Francisco, CA 94143-0124, USA. erame@medicine.ucsf.edu
Insights
Pathologic cardiac hypertrophy, if untreated, leads to heart failure. Early prevention and treatment of heart failure are crucial for improving patient outcomes and preventing cardiovascular events.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Pathophysiology
Background:
- Left ventricular failure is a common outcome of various myocardial injuries like hypertension and infarction.
- Left ventricular hypertrophy, initially adaptive, becomes maladaptive and a risk factor for heart failure when untreated.
- The progression from cardiac hypertrophy to heart failure in humans remains incompletely understood.
Purpose of the Study:
- To elucidate the transition from cardiac hypertrophy to heart failure.
- To emphasize the importance of preventing heart failure and associated cardiovascular events.
- To outline current treatment strategies for established heart failure.
Main Methods:
- Review of existing literature on cardiac hypertrophy and heart failure.
- Analysis of the pathophysiology linking maladaptive hypertrophy to heart failure.
- Synthesis of current clinical guidelines for heart failure management.
Main Results:
- Untreated pathologic cardiac hypertrophy is a significant risk factor for heart failure development.
- Prevention of heart failure and cardiovascular events like stroke and atrial fibrillation is a primary treatment goal.
- Medical and device therapies aim to improve function, survival, and prevent progression in heart failure patients.
Conclusions:
- Understanding the transition from hypertrophy to heart failure is critical for effective prevention and treatment.
- Proactive management of cardiovascular risk factors and early intervention are key.
- Comprehensive treatment strategies are necessary for patients with established heart failure to improve quality of life and prognosis.
Abstract:
Left ventricular failure is the final common pathway for a wide spectrum of myocardial insults, including systemic hypertension and myocardial infarction. Although left ventricular hypertrophy is an adaptive response to pressure and volume overload, this process becomes maladaptive if left untreated and pathologic cardiac hypertrophy then becomes an important and independent risk factor for the development of heart failure. Despite its importance, the transition from hypertrophy to heart failure in humans is poorly understood. The focus of treatment should be prevention of heart failure and other cardiovascular events, such as stroke and atrial fibrillation. When heart failure is present, treatment with medical and device therapy is then focused on improving functional capacity, increasing survival, and preventing progression to end-stage heart failure.
Related Concept Videos
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Regurgitation I: Introduction
